生物保存市场报告：2031 年趋势、预测与竞争分析

全球生物保存市场前景光明，医院、生物库和基因库市场充满机会。预计到 2031 年，全球生物保存市场规模将达到 170 亿美元，2025 年至 2031 年的复合年增长率为 28.1%。该市场的主要驱动力是研发投资的增加、生物银行的进步、新生儿脐带血干细胞保存趋势的日益增长、再生医学研究投资的增加以及个人化医疗需求的不断增长。

• Lucintel 预测，按类型划分，由于对生物银行的需求不断增加、在 DNA、血浆、干细胞和组织研究中的广泛应用、广泛的采用、高成本效益和低维护，预计预测期内仪器将出现高增长。
• 从最终用途产业来看，生物库预计将继续保持最大的份额，这得益于研究人员对生物保存意识的不断提高、精子库和卵子库数量的不断增加、辅助生殖技术的采用、生物製药公司与国家生物库的合作以及医院的组织保存中心。
• 从地区来看，由于生物医学研究领域的持续药物开发和先进治疗、需要高端慢性病治疗的患者数量不断增加以及对生物保存产品和服务的需求很高，预计北美将在预测期内实现最高增长。

生物保存市场的策略性成长机会

由于技术进步和各领域的应用不断扩大，生物保存市场正在迅速扩大。多个应用领域正在出现关键的成长机会，反映出对有效保存方法的需求日益增长，以确保生物材料的品质和完整性。这些机会涵盖生物银行、再生医学、药物开发、诊断和个人化医疗等领域。了解这些成长机会将有助于相关人员调整策略，以利用市场成长和创新。

• 生物库的扩张：由于对大型、高品质生物样本库的需求不断增加，生物库成为关键的成长领域。先进的生物库基础设施和改进的样本管理技术的发展使得样本的收集、储存和利用更加容易。此次扩建将透过提供各种保存完好的生物样本来支持基因组学、个人化医疗和药物发现研究。对生物库基础设施的投资可以增强研究能力，促进对疾病的理解和发展标靶治疗的突破。
• 再生医学的进展：再生医学为生物保存提供了重大的成长机会。干细胞治疗和组织工程等技术需要精确的保存方法来维持细胞活力和功能。冷冻保存和保存技术的创新对于支援这些应用至关重要。随着再生医学的进步，对可靠的生物保存解决方案的需求不断增加，这为公司提供了发展专业机会以满足再生疗法的独特要求并提高其有效性的机会。
• 药物开发的成长：随着製药业专注于生物製药和复杂药物，对先进的生物保存方法的需求日益增加。单株抗体、疫苗等生技药品的保存需要严格控制储存条件，以确保产品的稳定性和有效性。我们有机会开发新的保存技术来提高这些易碎产品的保质期和处理能力。随着製药公司寻求优化其生物保存流程，该领域具有巨大的成长潜力。
• 诊断测试的创新：诊断测试的复杂性和数量的不断增加为诊断样本的管理和储存创造了生物保存的机会。保存技术的进步可以提高诊断样本的品质、准确性和可靠性。开发能够处理多种样本类型（包括血液、组织和遗传物质）的强大生物保存解决方案对于支援不断发展的诊断产业至关重要。这将为创新保存技术创造一个利基市场，从而提高诊断测试能力。
• 个人化医疗：个人化医疗正在迅速发展，需要先进的生物保存解决方案来根据个人的基因特征量身定制治疗方案。基因组、蛋白质组和其他生物资料的储存对于个人化治疗的开发和实施至关重要。公司有机会建立专门的生物保存系统，支援个人化医疗研究和应用的扩展。满足个人化医疗的独特需求使生物保存供应商能够进入专注于个人化患者照护的新兴市场。

生物保存的策略性成长机会涵盖生物库、再生医学、药物开发、诊断测试和个人化医疗。每个应用都为创新和市场扩张提供了独特的机会。透过利用这些机会，相关人员可以加强他们的产品，支持相关领域的进步，并为整个生物保存市场的成长做出贡献。

生物保存市场驱动因素与挑战

生物保存市场受到各种市场驱动因素和挑战的影响，包括技术进步、经济因素和法律规范。了解这些因素对于把握市场和发现成长机会至关重要。以下分析探讨了影响生物保存产业的关键驱动因素和挑战，并强调了它们的意义和影响。

生物保存市场的驱动因素包括：

• 技术进步：冷冻保存、保存系统和监测技术的进步是推动生物保存市场成长的主要因素。改进的冷冻保护剂、自动化保存解决方案和即时监控系统等进步使得保存方法更加高效和可靠。这些技术解决了先前的限制，降低了成本，并支持研究、医学和个人化医疗领域新应用的开发。
• 生物库需求不断增加：生物库需求不断增加是生物保存市场的主要驱动力。生物库对于储存用于研究和临床应用的大量生物样本至关重要。个人化医疗、基因组学和药物研发的进步推动了对大量、保存良好的样本库的需求。对生物库基础设施和技术的投资对于满足此需求和支援正在进行的研究和开发至关重要。
• 再生医学的发展：包括干细胞疗法和组织工程在内的再生医学的兴起正在推动对先进生物保存方法的需求。有效保存细胞、组织和器官对于维持其活力和功能至关重要。冷冻保存和储存技术的创新满足了再生医学的独特需求，为开发专门保存解决方案的公司创造了成长机会。
• 製药和生物製药市场的扩张：由于生物生技药品和复杂药物的发展，製药和生物製药市场的发展正在推动对生物保存解决方案的需求。生物製药需要严格的储存条件以确保稳定性和功效。保质技术的进步可以延长这些产品的保质期并改善其处理方式，对于支持该行业的发展至关重要。
• 日益关注个人化医疗：个人化医疗需要先进的遗传、蛋白质组和其他生物资料储存方法，从而推动生物保存市场的成长。根据个人情况量身定制治疗方案的能力需要准确储存生物样本。对个人化医疗的关注为支持收集、储存和分析各种生物资料的生物保存解决方案的开发创造了机会。

生物保存市场面临的挑战是：

• 先进技术成本高：先进生物保存技术的高成本可能是一个主要障碍。投资最先进的冷冻保存系统、储存设施和监测设备需要大量资金。对于中小企业和研究机构来说，这些成本会限制他们获得最新技术，并影响他们在市场上的竞争力。
• 法规遵循：遵守严格的法规要求对生物保存市场来说是一项挑战。关于生物材料的储存和物料输送的规定很复杂，并且因地区而异。确保遵守这些法规需要不断更新保存方法并投资于品管措施，这对于在多个司法管辖区运营的公司来说可能是资源密集的。
• 技术整合和标准化：将新技术整合到现有系统中并实现整个产业的标准化是一项挑战。生物保存实践缺乏统一的标准可能导致样本品质和保存结果的差异。标准化协议和技术的开发和采用对于确保可靠性和整个市场的广泛采用至关重要。

生物保存市场受到各种驱动因素​​和挑战的影响。技术进步、生物库需求的增加、再生医学的成长、医药市场的扩大以及对个人化医疗的关注是推动市场成长的主要因素。然而，高成本、法规遵循和技术整合挑战正在影响市场动态。应对这些挑战并利用便利因素对于相关人员有效驾驭不断发展的生物保护格局至关重要。

目录

第一章执行摘要

第二章全球生物保存市场：市场动态

• 简介、背景和分类
• 供应链
• 产业驱动力与挑战

第三章 2019年至2031年市场趋势及预测分析

• 宏观经济趋势（2019-2024）及预测（2025-2031）
• 全球生物保存市场趋势（2019-2024）及预测（2025-2031）
• 按类型
  • 媒体
  • 装置
• 透过生物检体
  • 人体组织
  • 干细胞
  • 器官
• 按应用
  • 治疗
  • 调查
  • 临床试验
• 全球生物防腐市场（按最终用途行业划分）
  • 医院
  • 生物样本库
  • 基因库
  • 其他的

第四章2019年至2031年区域市场趋势与预测分析

• 按地区划分：全球生物防腐市场
• 北美生物保存市场
• 欧洲生物防腐市场
• 亚太生物保存市场
• 其他地区的生物保存市场

第五章 竞争分析

• 产品系列分析
• 营运整合
• 波特五力分析

第六章 成长机会与策略分析

• 成长机会分析
  • 按类型
  • 透过生物检体
  • 按应用
  • 按最终用途行业
  • 按地区
• 全球生物保存市场的新趋势
• 战略分析
  • 新产品开发
  • 全球生物保存市场容量不断扩大
  • 全球生物保存市场的合併、收购和合资企业
  • 认证和许可

第七章主要企业简介

• Thermo Fisher Scientific
• Merck
• Avantor
• ThermoGenesis
• Bio-Techne Corporation
• BioLife Solutions
• Exact Sciences Corporation
• Worthington Industries
• Chart Industries

The future of the global biopreservation market looks promising with opportunities in the hospital, biobank, and gene bank markets. The global biopreservation market is expected to reach an estimated $17 billion by 2031 with a CAGR of 28.1% from 2025 to 2031. The major drivers for this market are increasing R&D investments, advancements in biobanking, the growing trend of conserving cord blood stem cells of newborns, rising investments in regenerative medicine research, and increasing demand for personalized medicine.

• Lucintel forecasts that, Within the type category, equipment is expected to witness higher growth over the forecast period due to increasing demand for bio-banks, extensive usage in DNA, plasma, stem cell, and tissue research, widespread adoption, high-cost efficiency, and low maintenance.
• Within the end use industry category, biobanks will remain the largest segment due to growing awareness of biopreservation among researchers, an increasing number of sperm and egg banks, the adoption of assisted reproductive technology, a collaboration of biopharmaceutical companies with national bio-banks, and tissue preservation centers at hospitals.
• In terms of regions, North America is expected to witness the highest growth over the forecast period due to consistent drug developments and advanced therapies in the field of biomedical research, rise in patient base requiring high-end treatment for chronic diseases, and high demand for biopreservation products and services.

Gain valuable insights for your business decisions with our comprehensive 150+ page report.

Emerging Trends in the Biopreservation Market

The biopreservation market is witnessing several transformative trends that reshape the field. These trends reflect advancements in technology, evolving market demands, and the growing importance of maintaining the integrity of biological materials. Understanding these trends helps stakeholders anticipate future developments and adapt their strategies accordingly.

• Increased Use of Artificial Intelligence (AI): AI is revolutionizing biopreservation by enhancing the monitoring and management of storage conditions. AI-driven systems analyze real-time data to optimize preservation protocols, predict potential issues, and automate responses. This technology improves the reliability and efficiency of biopreservation processes, reducing human error and ensuring better outcomes for biological samples. AI's predictive capabilities also facilitate proactive maintenance of preservation equipment, minimizing risks and extending sample viability.
• Sustainable Biopreservation Solutions: There is a growing emphasis on sustainable biopreservation methods, driven by environmental concerns and regulatory pressures. Innovations include the development of eco-friendly cryoprotectants and energy-efficient storage systems. These solutions aim to reduce the environmental footprint of biopreservation processes while maintaining high standards of sample integrity. Sustainable practices are becoming essential for companies looking to enhance their corporate responsibility and comply with emerging environmental regulations.
• Advances in Cryopreservation Technologies: Cryopreservation continues to evolve, with new technologies improving sample storage and recovery. Recent advancements include enhanced cryoprotectants that reduce ice crystal formation and novel cooling techniques that improve cell viability. These innovations address previous limitations in cryopreservation, such as damage during thawing and long-term storage challenges, thereby supporting the growing demand for high-quality biological samples in research and clinical applications.
• Expansion of Biobanking Facilities: The expansion of biobanking is a significant trend, driven by the increasing demand for biological samples in research and personalized medicine. New biobank facilities are being established globally, focusing on increasing capacity and improving sample management. This expansion supports advancements in genomics, proteomics, and other fields, providing researchers with diverse and high-quality sample repositories for studying diseases, developing treatments, and advancing scientific knowledge.
• Integration of Regenerative Medicine and Biopreservation: The integration of regenerative medicine with biopreservation is transforming the field, particularly in stem cell research and cell therapies. Advances in biopreservation techniques are critical for maintaining the viability of cells and tissues used in regenerative medicine. Innovations in storage methods and cryopreservation protocols enhance the effectiveness of cell-based therapies and support the development of personalized treatments, making biopreservation a key component in the future of regenerative medicine.

These emerging trends significantly reshape the biopreservation market by driving innovation, enhancing sustainability, and expanding capabilities. AI and advanced technologies improve efficiency and reliability, while sustainable practices address environmental concerns. The growth of biobanking facilities and the integration of regenerative medicine further highlight the evolving landscape. Together, these trends set new standards for biopreservation, supporting advances in research, clinical applications, and personalized medicine.

Recent Developments in the Biopreservation Market

The biopreservation market reflects advancements in technology, regulatory frameworks, and market demands. These key developments transform how biological materials are preserved, with significant implications for research, pharmaceuticals, and healthcare. Understanding these developments provides insight into how the market evolves and the factors driving innovation in biopreservation.

• Development of Advanced Cryopreservation Systems: Recent advancements in cryopreservation systems have led to improved preservation of biological materials. New technologies, such as advanced cryoprotectants and more efficient cooling methods, enhance cell viability and reduce damage during thawing. These systems address previous limitations and support the growing demand for high-quality samples in research and clinical applications. The development of these systems is crucial for maintaining the integrity of biological samples and advancing scientific and medical research.
• Growth of Biobank Infrastructure: The expansion of biobank infrastructure is a notable development, with new facilities established worldwide. This growth supports the increasing need for biological samples in research and personalized medicine. Enhanced biobank infrastructure includes improved sample management systems, larger storage capacities, and better data integration. This development facilitates more extensive and diverse research, contributing to advancements in genomics, proteomics, and disease understanding.
• Innovations in Sample Storage Technologies: Innovations in sample storage technologies drive improvements in biopreservation. Advances include the development of energy-efficient storage systems and novel materials that enhance sample stability. These innovations address the challenges of long-term storage and reduce operational costs. Improved storage technologies ensure the integrity of biological samples, supporting their use in research and clinical applications.
• Enhanced Regulatory Frameworks: Enhanced regulatory frameworks shape the biopreservation market by setting higher standards for sample preservation and management. Recent changes in regulations focus on ensuring the quality and safety of biological materials. Compliance with these regulations requires the adoption of advanced preservation techniques and rigorous quality control measures. These regulatory developments support the growth of the biopreservation market by establishing clear guidelines and promoting best practices.
• Increased Focus on Personalized Medicine: The increasing focus on personalized medicine drives advancements in biopreservation. Personalized medicine relies on high-quality biological samples for developing tailored treatments and therapies. Recent developments include improved preservation methods that support the storage and analysis of samples for personalized medicine applications. This focus on personalized medicine expands the role of biopreservation in drug development and patient care.

The biopreservation market enhances preservation techniques, expands infrastructure, and improves regulatory standards. Advances in cryopreservation systems, biobank growth, and storage technologies are crucial for maintaining sample integrity. Enhanced regulations and the focus on personalized medicine further shape the market, driving innovation and supporting the evolution of biopreservation practices. These developments collectively contribute to the advancement of research, pharmaceuticals, and healthcare.

Strategic Growth Opportunities for Biopreservation Market

The biopreservation market is expanding rapidly, driven by technological advancements and growing applications across various sectors. Key growth opportunities are emerging in several applications, reflecting the increasing need for effective preservation methods to ensure the quality and integrity of biological materials. These opportunities span areas such as biobanking, regenerative medicine, pharmaceutical development, diagnostics, and personalized medicine. Understanding these opportunities helps stakeholders align their strategies to capitalize on market growth and innovation.

• Expansion in Biobanking: Biobanking is a significant growth area due to the increasing demand for large-scale, high-quality biological sample repositories. The development of advanced biobank infrastructure and improved sample management technologies enable better collection, storage, and utilization of samples. This expansion supports research in genomics, personalized medicine, and drug discovery by providing a diverse range of well-preserved biological materials. Investment in biobanking infrastructure can enhance research capabilities and facilitate breakthroughs in understanding diseases and developing targeted therapies.
• Advancements in Regenerative Medicine: Regenerative medicine creates substantial growth opportunities in biopreservation. Techniques such as stem cell therapy and tissue engineering require precise preservation methods to maintain cell viability and functionality. Innovations in cryopreservation and storage technologies are critical for supporting these applications. As regenerative medicine advances, the need for reliable biopreservation solutions grows, providing opportunities for companies to develop specialized technologies that cater to the unique requirements of regenerative therapies and enhance their efficacy.
• Growth in Pharmaceutical Development: The pharmaceutical industry's focus on biopharmaceuticals and complex drugs drives demand for advanced biopreservation methods. The preservation of biologics, such as monoclonal antibodies and vaccines, requires stringent control over storage conditions to ensure product stability and efficacy. Opportunities exist for developing new preservation technologies that improve the shelf life and handling of these sensitive products. As pharmaceutical companies seek to optimize their biopreservation processes, there is potential for significant growth in this sector.
• Innovations in Diagnostic Testing: The increasing complexity and volume of diagnostic testing create opportunities for biopreservation in managing and storing diagnostic samples. Advances in preservation technologies can improve sample quality, accuracy, and reliability in diagnostics. The development of robust biopreservation solutions that can handle diverse types of samples, including blood, tissue, and genetic material, is crucial for supporting the growing diagnostic industry. This creates a niche market for innovative preservation technologies that enhance diagnostic testing capabilities.
• Personalized Medicine: Personalized medicine is expanding rapidly, necessitating advanced biopreservation solutions for tailoring treatments based on individual genetic profiles. The preservation of genomic, proteomic, and other biological data is essential for developing and delivering personalized therapies. Companies have opportunities to create specialized biopreservation systems that support the growing volume of personalized medicine research and applications. By addressing the specific needs of personalized medicine, biopreservation providers can tap into a burgeoning market focused on individualized patient care.

The strategic growth opportunities in biopreservation span biobanking, regenerative medicine, pharmaceutical development, diagnostic testing, and personalized medicine. Each application presents unique opportunities for technological innovation and market expansion. By leveraging these opportunities, stakeholders can enhance their offerings, support advancements in related fields, and contribute to the overall growth of the biopreservation market.

Biopreservation Market Driver and Challenges

The biopreservation market is influenced by a range of drivers and challenges, including technological advancements, economic factors, and regulatory frameworks. Understanding these factors is crucial for navigating the market and identifying growth opportunities. The following analysis explores the key drivers and challenges shaping the biopreservation industry, highlighting their implications and impact.

The factors responsible for driving the biopreservation market include:

• Technological Advancements: Technological innovations in cryopreservation, storage systems, and monitoring technologies are major drivers of growth in the biopreservation market. Advances such as improved cryoprotectants, automated storage solutions, and real-time monitoring systems enhance the efficiency and reliability of preservation methods. These technologies address previous limitations, reduce costs, and support the development of new applications in research, pharmaceuticals, and personalized medicine.
• Increasing Demand for Biobanking: The growing demand for biobanking is a significant driver of the biopreservation market. Biobanks are essential for storing large volumes of biological samples for research and clinical applications. As personalized medicine, genomics, and drug discovery advance, the need for extensive and well-preserved sample repositories increases. Investment in biobank infrastructure and technologies is crucial for meeting this demand and supporting ongoing research and development efforts.
• Growth of Regenerative Medicine: The rise of regenerative medicine, including stem cell therapies and tissue engineering, is driving demand for advanced biopreservation methods. Effective preservation of cells, tissues, and organs is essential for maintaining their viability and functionality. Innovations in cryopreservation and storage techniques cater to the specific needs of regenerative medicine, creating growth opportunities for companies developing specialized preservation solutions.
• Expansion of Pharmaceutical and Biopharmaceutical Markets: The expansion of the pharmaceutical and biopharmaceutical markets, driven by the development of biologics and complex drugs, is fueling demand for biopreservation solutions. Biopharmaceuticals require stringent preservation conditions to ensure stability and efficacy. Advances in preservation technologies that enhance the shelf life and handling of these products are critical for supporting the growth of this sector.
• Increasing Focus on Personalized Medicine: Personalized medicine drives growth in the biopreservation market by requiring advanced preservation methods for genetic, proteomic, and other biological data. The ability to tailor treatments based on individual profiles necessitates precise preservation of biological samples. This focus on personalized medicine creates opportunities for developing biopreservation solutions that support the collection, storage, and analysis of diverse biological data.

Challenges in the biopreservation market are:

• High Costs of Advanced Technologies: The high costs associated with advanced biopreservation technologies can be a significant barrier. Investment in cutting-edge cryopreservation systems, storage facilities, and monitoring equipment requires substantial financial resources. For smaller companies and research institutions, these costs can limit access to the latest technologies and impact their ability to compete in the market.
• Regulatory Compliance: Compliance with stringent regulatory requirements poses a challenge for the biopreservation market. Regulations governing the storage and handling of biological materials are complex and vary by region. Ensuring adherence to these regulations requires continuous updates to preservation practices and investments in quality control measures, which can be resource-intensive for companies operating in multiple jurisdictions.
• Technological Integration and Standardization: Integrating new technologies with existing systems and achieving standardization across the industry can be challenging. The lack of uniform standards for biopreservation practices can lead to inconsistencies in sample quality and preservation outcomes. Developing and adopting standardized protocols and technologies is essential for ensuring reliability and facilitating widespread adoption across the market.

The biopreservation market is shaped by various drivers and challenges. Technological advancements, increasing demand for biobanking, growth in regenerative medicine, expansion of pharmaceutical markets, and the focus on personalized medicine are key drivers propelling market growth. However, high costs, regulatory compliance, and technological integration challenges impact the market's dynamics. Addressing these challenges while leveraging growth drivers will be crucial for stakeholders to navigate the evolving biopreservation landscape effectively.

List of Biopreservation Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. through these strategies biopreservation companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the biopreservation companies profiled in this report include-

• Thermo Fisher Scientific
• Merck
• Avantor
• ThermoGenesis
• Bio-Techne Corporation
• BioLife Solutions
• Exact Sciences Corporation
• Worthington Industries
• Chart Industries

Biopreservation by Segment

The study includes a forecast for the global biopreservation by type, biospecimen, application, end use industry, and region.

Biopreservation Market by Type [Analysis by Value from 2019 to 2031]:

• Media
• Equipment

Biopreservation Market by Biospecimen [Analysis by Value from 2019 to 2031]:

• Human Tissue
• Stem Cells
• Organs

Biopreservation Market by Application [Analysis by Value from 2019 to 2031]:

• Therapeutics
• Research
• Clinical Trials

Biopreservation Market by End Use Industry [Analysis by Value from 2019 to 2031]:

• Hospitals
• Biobanks
• Gene Banks
• Others

Biopreservation Market by Region [Analysis by Value from 2019 to 2031]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Biopreservation Market

The biopreservation market is experiencing rapid advancements driven by innovations in technology, regulatory changes, and increasing demand for quality and safety in biopharmaceuticals and healthcare. These developments reshape how biological samples and products are preserved, extending their shelf life and ensuring their integrity. This analysis explores recent developments in the United States, China, Germany, India, and Japan, highlighting key advancements and shifts in each region's biopreservation landscape.

• United States: In the U.S., the biopreservation market is driven by innovations in cryopreservation and the adoption of advanced biopreservation systems. Recent developments include the integration of artificial intelligence for monitoring and optimizing storage conditions. Additionally, the FDA's regulatory support for personalized medicine has spurred growth in biobanking, enhancing research capabilities. Companies are investing in more sophisticated refrigeration technologies and data management systems to ensure the integrity of biological samples, facilitating advances in drug development and personalized therapies.
• China: China is rapidly advancing in biopreservation due to increasing investments in biotechnology and healthcare infrastructure. Recent developments include significant improvements in cryopreservation techniques and the establishment of large-scale biobanks. The government has also implemented supportive policies to foster innovation and collaboration in biopreservation research. Chinese firms focus on developing cost-effective and efficient biopreservation solutions to support the growing demand for biological samples in research and clinical applications, positioning the country as a key player in the global market.
• Germany: Germany is leading in the European biopreservation market with a strong emphasis on technological innovation and sustainability. Recent advancements include the development of new materials and technologies for more efficient cryopreservation and storage. German companies are also exploring novel biopreservation methods that reduce environmental impact, such as eco-friendly cryoprotectants. The country's robust research infrastructure and collaboration between academia and industry drive advancements in preserving biological materials for pharmaceutical and research purposes.
• India: India is making strides in biopreservation, particularly in the context of biobanking and pharmaceutical research. Recent developments include the expansion of biobank facilities and improvements in cryopreservation technologies tailored to regional needs. Indian companies and research institutions increasingly adopt advanced preservation techniques to enhance the quality and reliability of biological samples. Government initiatives and private investments boost the biopreservation sector, supporting growth in personalized medicine and research capabilities.
• Japan: The Japanese biopreservation market is characterized by its focus on high-tech solutions and integration with cutting-edge research. Recent developments include advancements in cryopreservation technology and the adoption of sophisticated biopreservation systems. Japan is also at the forefront of developing new preservation techniques to support regenerative medicine and cell therapies. The country's strong emphasis on innovation and its supportive regulatory environment drive the evolution of biopreservation practices, enhancing the quality and efficiency of biological sample storage.

Features of the Global Biopreservation Market

Market Size Estimates: Biopreservation market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.

Segmentation Analysis: Biopreservation market size by various segments, such as by type, biospecimen, application, end use industry, and region in terms of value ($B).

Regional Analysis: Biopreservation market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different type, biospecimen, application, end use industry, and regions for the biopreservation market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the biopreservation market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the biopreservation market by type (media and equipment), biospecimen (human tissue, stem cells, and organs), application (therapeutics, research, and clinical trials), end use industry (hospitals, biobanks, gene banks, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Biopreservation Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2019 to 2031

• 3.1. Macroeconomic Trends (2019-2024) and Forecast (2025-2031)
• 3.2. Global Biopreservation Market Trends (2019-2024) and Forecast (2025-2031)
• 3.3: Global Biopreservation Market by Type
  • 3.3.1: Media
  • 3.3.2: Equipment
• 3.4: Global Biopreservation Market by Biospecimen
  • 3.4.1: Human Tissue
  • 3.4.2: Stem Cells
  • 3.4.3: Organs
• 3.5: Global Biopreservation Market by Application
  • 3.5.1: Therapeutics
  • 3.5.2: Research
  • 3.5.3: Clinical Trials
• 3.6: Global Biopreservation Market by End Use Industry
  • 3.6.1: Hospitals
  • 3.6.2: Biobanks
  • 3.6.3: Gene Banks
  • 3.6.4: Others

4. Market Trends and Forecast Analysis by Region from 2019 to 2031

• 4.1: Global Biopreservation Market by Region
• 4.2: North American Biopreservation Market
  • 4.2.1: North American Biopreservation Market by Type: Media and Equipment
  • 4.2.2: North American Biopreservation Market by End Use Industry: Hospitals, Biobanks, Gene Banks, and Others
• 4.3: European Biopreservation Market
  • 4.3.1: European Biopreservation Market by Type: Media and Equipment
  • 4.3.2: European Biopreservation Market by End Use Industry: Hospitals, Biobanks, Gene Banks, and Others
• 4.4: APAC Biopreservation Market
  • 4.4.1: APAC Biopreservation Market by Type: Media and Equipment
  • 4.4.2: APAC Biopreservation Market by End Use Industry: Hospitals, Biobanks, Gene Banks, and Others
• 4.5: ROW Biopreservation Market
  • 4.5.1: ROW Biopreservation Market by Type: Media and Equipment
  • 4.5.2: ROW Biopreservation Market by End Use Industry: Hospitals, Biobanks, Gene Banks, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Biopreservation Market by Type
  • 6.1.2: Growth Opportunities for the Global Biopreservation Market by Biospecimen
  • 6.1.3: Growth Opportunities for the Global Biopreservation Market by Application
  • 6.1.4: Growth Opportunities for the Global Biopreservation Market by End Use Industry
  • 6.1.5: Growth Opportunities for the Global Biopreservation Market by Region
• 6.2: Emerging Trends in the Global Biopreservation Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Biopreservation Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Biopreservation Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Thermo Fisher Scientific
• 7.2: Merck
• 7.3: Avantor
• 7.4: ThermoGenesis
• 7.5: Bio-Techne Corporation
• 7.6: BioLife Solutions
• 7.7: Exact Sciences Corporation
• 7.8: Worthington Industries
• 7.9: Chart Industries